These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23598247)

  • 1. Lead optimization of 5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxyhexanamides to reduce a cardiac safety issue: discovery of DS-8108b, an orally active renin inhibitor.
    Nakamura Y; Fujimoto T; Ogawa Y; Namiki H; Suzuki S; Asano M; Sugita C; Mochizuki A; Miyazaki S; Tamaki K; Nagai Y; Inoue S; Nagayama T; Kato M; Chiba K; Takasuna K; Nishi T
    Bioorg Med Chem; 2013 Jun; 21(11):3175-96. PubMed ID: 23598247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors.
    Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Fujimoto T; Sugita C; Miyazaki S; Tamaki K; Nagayama T; Nagai Y; Inoue S; Chiba K; Nishi T
    Bioorg Med Chem; 2013 Sep; 21(18):5907-22. PubMed ID: 23886807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and optimization of renin inhibitors: Orally bioavailable alkyl amines.
    Tice CM; Xu Z; Yuan J; Simpson RD; Cacatian ST; Flaherty PT; Zhao W; Guo J; Ishchenko A; Singh SB; Wu Z; Scott BB; Bukhtiyarov Y; Berbaum J; Mason J; Panemangalore R; Cappiello MG; Müller D; Harrison RK; McGeehan GM; Dillard LW; Baldwin JJ; Claremon DA
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3541-5. PubMed ID: 19457666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension.
    Chen A; Bayly C; Bezençon O; Richard-Bildstein S; Dubé D; Dubé L; Gagné S; Gallant M; Gaudreault M; Grimm E; Houle R; Lacombe P; Laliberté S; Lévesque JF; Liu S; MacDonald D; Mackay B; Martin D; McKay D; Powell D; Remen L; Soisson S; Toulmond S
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2204-9. PubMed ID: 20206513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
    Ryan MJ; Hicks GW; Batley BL; Rapundalo ST; Patt WC; Taylor DG; Keiser JA
    J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SC-56525, a potent, orally active renin inhibitor, in salt-depleted and renal hypertensive dogs.
    McMahon EG; Yang PC; Babler MA; Bittner SE; Suleymanov OD; Cain-Janicki KJ; Bedell LJ; Hanson GJ; Cook CS
    Hypertension; 1995 Jul; 26(1):95-100. PubMed ID: 7607739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets.
    Maibaum J; Stutz S; Göschke R; Rigollier P; Yamaguchi Y; Cumin F; Rahuel J; Baum HP; Cohen NC; Schnell CR; Fuhrer W; Gruetter MG; Schilling W; Wood JM
    J Med Chem; 2007 Oct; 50(20):4832-44. PubMed ID: 17824680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin.
    Rahuel J; Rasetti V; Maibaum J; Rüeger H; Göschke R; Cohen NC; Stutz S; Cumin F; Fuhrer W; Wood JM; Grütter MG
    Chem Biol; 2000 Jul; 7(7):493-504. PubMed ID: 10903938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An orally active renin inhibitor: cyclohexylnorstatine-containing dipeptide (KRI-1314).
    Miyazaki M; Etoh Y; Iizuka K; Toda N
    J Hypertens Suppl; 1989 Apr; 7(2):S25-7. PubMed ID: 2666609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The P1N-isopropyl motif bearing hydroxyethylene dipeptide isostere analogues of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin.
    Yamaguchi Y; Menear K; Cohen NC; Mah R; Cumin F; Schnell C; Wood JM; Maibaum J
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4863-7. PubMed ID: 19615901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery and synthesis of potent zwitterionic inhibitors of renin.
    Aspiotis R; Chen A; Cauchon E; Dubé D; Falgueyret JP; Gagné S; Gallant M; Grimm EL; Houle R; Juteau H; Lacombe P; Laliberté S; Lévesque JF; MacDonald D; McKay D; Percival MD; Roy P; Soisson SM; Wu T
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2430-6. PubMed ID: 21429746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of spirocyclic piperidines.
    Chen A; Aspiotis R; Campeau LC; Cauchon E; Chefson A; Ducharme Y; Falgueyret JP; Gagné S; Han Y; Houle R; Laliberté S; Larouche G; Lévesque JF; McKay D; Percival D
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7399-404. PubMed ID: 22071301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines.
    Chen A; Cauchon E; Chefson A; Dolman S; Ducharme Y; Dubé D; Falgueyret JP; Fournier PA; Gagné S; Gallant M; Grimm E; Han Y; Houle R; Huang JQ; Hughes G; Jûteau H; Lacombe P; Lauzon S; Lévesque JF; Liu S; Macdonald D; Mackay B; McKay D; Percival MD; St-Jacques R; Toulmond S
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3976-81. PubMed ID: 21641209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,4-Diarylpiperidines as potent renin inhibitors.
    Lacombe P; Arbour M; Aspiotis R; Cauchon E; Chen A; Dubé D; Falgueyret JP; Fournier PA; Gallant M; Grimm E; Han Y; Juteau H; Liu S; Mellon C; Ramtohul Y; Simard D; St-Jacques R; Tsui GC
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1953-7. PubMed ID: 22325946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin.
    Göschke R; Stutz S; Rasetti V; Cohen NC; Rahuel J; Rigollier P; Baum HP; Forgiarini P; Schnell CR; Wagner T; Gruetter MG; Fuhrer W; Schilling W; Cumin F; Wood JM; Maibaum J
    J Med Chem; 2007 Oct; 50(20):4818-31. PubMed ID: 17824679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery of novel potent trans-3,4-disubstituted pyrrolidine inhibitors of the human aspartic protease renin from in silico three-dimensional (3D) pharmacophore searches.
    Lorthiois E; Breitenstein W; Cumin F; Ehrhardt C; Francotte E; Jacoby E; Ostermann N; Sellner H; Kosaka T; Webb RL; Rigel DF; Hassiepen U; Richert P; Wagner T; Maibaum J
    J Med Chem; 2013 Mar; 56(6):2207-17. PubMed ID: 23425156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo.
    Thaisrivongs S; Pals DT; Harris DW; Kati WM; Turner SR
    J Med Chem; 1986 Oct; 29(10):2088-93. PubMed ID: 3531518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor.
    Nakamura Y; Fujimoto T; Ogawa Y; Sugita C; Miyazaki S; Tamaki K; Takahashi M; Matsui Y; Nagayama T; Manabe K; Mizuno M; Masubuchi N; Chiba K; Nishi T
    ACS Med Chem Lett; 2012 Sep; 3(9):754-8. PubMed ID: 24900544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile.
    Tokuhara H; Imaeda Y; Fukase Y; Iwanaga K; Taya N; Watanabe K; Kanagawa R; Matsuda K; Kajimoto Y; Kusumoto K; Kondo M; Snell G; Behnke CA; Kuroita T
    Bioorg Med Chem; 2018 Jul; 26(12):3261-3286. PubMed ID: 29754833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of potent, isoxazole-containing renin inhibitors.
    Fournier PA; Arbour M; Cauchon E; Chen A; Chefson A; Ducharme Y; Falgueyret JP; Gagné S; Grimm E; Han Y; Houle R; Lacombe P; Lévesque JF; MacDonald D; Mackay B; McKay D; Percival MD; Ramtohul Y; St-Jacques R; Toulmond S
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2670-4. PubMed ID: 22450130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.